NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Assets Average (2011 - 2026)

NextPlat's (NXPL) quarterly Assets Average came in at $27.8 million in Q2 2026, down 16.07% year-over-year from $33.1 million in Q2 2025, and up 2.22% quarter-over-quarter from $27.2 million in Q1 2026.

Analysis

NextPlat (NXPL) Assets Average (2011 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Assets Average for 14 consecutive years, with $27.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Assets Average fell 16.07% year-over-year to $27.8 million in Q2 2026; TTM through Jun 2026 was $27.8 million, a 16.07% decrease from a year earlier, with the FY2025 full-year figure at $32.3 million, down 36.44% from the prior year.
  • Assets Average was $27.8 million for Q2 2026 at NextPlat, up from $27.2 million in the prior quarter.
  • Over five years, Assets Average peaked at $65.3 million in Q4 2023 and troughed at $22.8 million in Q3 2022.
  • A 5-year average of $36.6 million and a median of $29.9 million in 2023 frame the typical range for Assets Average.
  • Across the five-year window, Assets Average surged 759.8% in 2022 and plunged 44.2% in 2025, its largest moves.
  • Over 5 years, Assets Average stood at $24.6 million in 2022, then soared by 165.69% to $65.3 million in 2023, then sank by 40.17% to $39.1 million in 2024, then decreased by 26.48% to $28.7 million in 2025, then retreated by 3.28% to $27.8 million in 2026.
  • The last three Assets Average figures came in at $27.8 million (Q2 2026), $27.2 million (Q1 2026), and $28.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 39.95 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 35.94 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 6.21 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 3.66 Bn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 24.65 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 1.46 Bn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 1.50 Bn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 1.70 Bn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 73.15 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 27.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.80 Mn
Mar 31, 2026 27.19 Mn
Dec 31, 2025 28.74 Mn
Sep 30, 2025 30.52 Mn
Jun 30, 2025 33.12 Mn
Mar 31, 2025 36.14 Mn
Dec 31, 2024 39.09 Mn
Sep 30, 2024 46.28 Mn
Jun 30, 2024 58.26 Mn
Mar 31, 2024 64.77 Mn
Dec 31, 2023 65.33 Mn
Sep 30, 2023 48.55 Mn
Jun 30, 2023 29.31 Mn
Mar 31, 2023 28.18 Mn
Dec 31, 2022 24.59 Mn
Sep 30, 2022 22.81 Mn
Jun 30, 2022 25.36 Mn
Mar 31, 2022 23.10 Mn
Dec 31, 2021 20.36 Mn
Sep 30, 2021 18.80 Mn